Identification and expression of microRNA-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR) in polycystic ovarian syndrome in South Indian population

1 Singh S, Pal N, Shubham S, et al. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.  J Clin Med 2023; 12:1454. https://doi.org/10.3390/jcm12041454 Search in Google Scholar

2 Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, et al. MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol 2020;15:261–78. https://doi.org/10.1007/s11523-020-00717-x. Search in Google Scholar

3 Menon, A., Abd-Aziz, N., Khalid, K., Poh, C. L., & Naidu, R. miRNA: A Promising Therapeutic Target in Cancer. International journal of molecular sciences 2022; 23:11502. https://doi.org/10.3390/ijms231911502 Search in Google Scholar

4 Zhu L, Yao X, Mo Y, Chen M, Li S, Liu J, et al. miR-4433a-3p promotes granulosa cell apoptosis by targeting peroxisome proliferator–activated receptor alpha and inducing immune cell infiltration in polycystic ovarian syndrome. J Assist Reprod Genet 2023;40:1447–59. https://doi.org/10.1007/s10815-023-02815-x. Search in Google Scholar

5 Fu, J., Imani, S., Wu, M. Y., & Wu, R. C. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.  Cancers 2023;  15:4723. https://doi.org/10.3390/cancers15194723 Search in Google Scholar

6 Krentowska, A., Ponikwicka-Tyszko, D., Łebkowska, A., Adamska, A., Sztachelska, M., Milewska, G., Hryniewicka, J., Wołczyński, S., & Kowalska, I. Serum expression levels of selected microRNAs and their association with glucose metabolism in young women with polycystic ovary syndrome. Polish archives of internal medicine 2024; 134:16637. https://doi.org/10.20452/pamw.16637 Search in Google Scholar

7 Han S, Zhao X, Zhang Y, Amevor FK, Tan B, Ma M, et al. MiR-34a-5p promotes autophagy and apoptosis of ovarian granulosa cells via the Hippo-YAP signaling pathway by targeting LEF1 in chicken. Poult Sci 2023;102:102374. https://doi.org/10.1016/j.psj.2022.102374. Search in Google Scholar

8 Rajkumar KV, Lakshmanan G, Sekar D. Identification of miR-802-5p and its involvement in type 2 diabetes mellitus. World J Diabetes 2020;11:567–71. https://doi.org/10.4239/wjd.v11.i12.567. Search in Google Scholar

9 Ahsan M, K P A, Usman P P A, Sekar D. Computational and expression analysis of microRNA-149-5p and its target, interleukin-6, in chronic kidney disease. Biomedical Research and Therapy 2023; 10:6103-6109. https://doi.org/10.15419/bmrat.v10i12.852 Search in Google Scholar

10 Ganesh A, Ashikha Shirin Usman P, K.P.A, Thomas P, Ganapathy D, Sekar D. Expression analysis of transforming growth factor beta (TGF-b) in oral squamous cell carcinoma. Oral Oncology Reports 2024; 9:100195. https://doi.org/10.1016/j.oor.2024.100195 Search in Google Scholar

11 Gong, Z., Yang, J., Bai, S., & Wei, S. MicroRNAs regulate granulosa cells apoptosis and follicular development - A review. Asian-Australasian journal of animal sciences 2020; 33:1714–1724. https://doi.org/10.5713/ajas.19.0707 Search in Google Scholar

12 Neuhausser, W. M., Faure-Kumar, E., Mahurkar-Joshi, S., Iliopoulos, D., & Sakkas, D. Identification of miR-34-3p as a candidate follicular phase serum marker for endometriosis: a pilot study. F&S science 2022; 3:269–278. https://doi.org/10.1016/j.xfss.2022.02.005 Search in Google Scholar

13 Luo, Y., Cui, C., Han, X., Wang, Q., & Zhang, C. The role of miRNAs in polycystic ovary syndrome with insulin resistance. Journal of assisted reproduction and genetics 2021; 38:289–304. https://doi.org/10.1007/ Search in Google Scholar

14 Ilieva M, Panella R, Uchida S. MicroRNAs in Cancer and Cardiovascular Disease. Cells 2022;11:3551. https://doi.org/10.3390/cells11223551 Search in Google Scholar

15 Panwar, V., Singh, A., Bhatt, M., Tonk, R. K., Azizov, S., Raza, A. S., Sengupta, S., Kumar, D., & Garg, M. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal transduction and targeted therapy 2023; 8:375. https://doi.org/10.1038/s41392-023-01608-z Search in Google Scholar

16 Szalai, F., Sztankovics, D., Krencz, I., Moldvai, D., Pápay, J., Sebestyén, A., & Khoor, A. Rictor-A Mediator of Progression and Metastasis in Lung Cancer.  Cancers 2024;  16:543. https://doi.org/10.3390/cancers16030543 Search in Google Scholar

17 Nakamura, M., Satoh, N., Horita, S., & Nangaku, M. Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential. Frontiers in pharmacology 2022; 13:1015204. https://doi.org/10.3389/fphar.2022.1015204s10815-020-02019-7 Search in Google Scholar